-
Stocks mixed with tech firms back under pressure
-
New Australia coach Kiss gives Japan starts to Ross, Amatosero
-
How Blundell's old school tactic ended England's 'Bazball' era
-
'Stretch our money': Romanians face highest EU inflation
-
Israel reports troop deaths as Lebanon talks underway in Rome
-
Iran says close to Hormuz plan with Oman, but reopening depends on US
-
Seeds Rybakina, Pegula, Gauff reach third round at WTA Toronto
-
Messi scores twice to set Leagues Cup record in Miami victory
-
Police raid South Korea FA in probe into World Cup coach appointment
-
Asian stocks mostly down with tech firms back under pressure
-
Low water on Germany's Rhine river threatens new blow to economy
-
Back to the future as world champion Springboks host All Blacks
-
Ex-Wallabies Foley, Phipps rejoin Waratahs ahead of home World Cup
-
India youth protests highlight mistrust in 'lapdog' media
-
Rising Kenyan lakes push crocodiles closer to homes
-
Pacific islands alarmed by Trump-backed push for deep-sea mining
-
Istanbul cymbals: From Ottoman war tool to pulse of global music
-
Erratic rains dictate menu at three-star Michelin restaurant in Brazil
-
Myanmar ex-junta chief on first Thailand trip as civilian leader
-
Zverev, Auger-Aliassime and Medvedev exit Montreal Masters
-
Environmental disaster looms as tanker leaks off Oman
-
Google-parent Alphabet shakes up AI division
-
Embattled Infantino sees minnows Malawi reach WAFCON quarter-finals
-
FIFA back Infantino, apologise for World Cup privatisation plan
-
Seeds Rybakina, Pegula and Gauff advance at WTA Toronto event
-
Auger-Aliassime out of Montreal ATP event with injury
-
Zverev, Auger-Aliassime exit star-short Montreal Masters
-
Colombian baby hippo of Escobar stock dies after rescue
-
Embattled FIFA chief Infantino in emergency talks in Morocco
-
Preakness shifts 2027 dates to entice more Derby horses
-
Castaway SpaceX rocket stage crashed into Moon, scientists say
-
Guatemalan volcano eruption ends, locals return home
-
Dow edges to record as markets parse prospects for Hormuz deal
-
WHO chief urges stronger Ebola response in DR Congo visit
-
Salah arrives in Turkey to complete Trabzonspor move
-
Newcastle appoint Jaissle as new head coach after Howe exit
-
AFP journalist to be honored at International Press Freedom Awards
-
Swiss ski star Lara Gut-Behrami calls time on 18-year career
-
Turkish MPs back limited amnesty for Kurdish militants
-
US indicts leaders of Mexico's CJNG cartel, ups reward money
-
Noosha Aubel: Czy poradzi sobie z problemami Poczdamu?
-
Noosha Aubel: Είναι σε θέση να αντιμετωπίσει τα προβλήματα του Πότσδαμ;
-
Noosha Aubel: Klarar hon av Potsdams problem?
-
نوشا أوبيل: هل هي على مستوى التحديات التي تواجهها بوتسدام؟
-
Noosha Aubel: Zvládne problémy Postupimi?
-
Former England fly-half Burns retires from rugby union
-
Brazil hits new diplomatic lows with US and Argentina
-
Pakistan beat West Indies by eight wickets to level series
-
NZ boxer Parker promises ring return after doping ban 'lifted'
-
Reusser holds lead as Vollering wins in Tour de France hills
Medicine Prize opens Nobel week clouded by war
Breast cancer discoveries and mRNA vaccines are seen as possible winners when the Nobel Medicine Prize kicks off a week of winner announcements on Monday, with this year's awards held under the shadow of war in Europe.
Established more than 120 years ago before Europe was ravaged by two world wars, the Nobel prizes will celebrate those who have "conferred the greatest benefit on mankind" after a year marked by bloodshed and devastation in Ukraine.
The Medicine Prize will be announced around 11:30 am (0930 GMT) in Stockholm on Monday, followed by the awards for physics on Tuesday, chemistry on Wednesday and literature on Thursday.
The Peace Prize, the most highly anticipated of the awards and the only one announced in Oslo, will follow on Friday, with the Economics Prize wrapping things up on October 10.
For medicine, one woman's name keeps popping up among prize watchers: US geneticist Mary-Claire King, who in 1990 discovered the BRCA1 gene responsible for a hereditary form of breast cancer.
She could be honoured together with oncologists Dennis Slamon of the United States and Germany's Axel Ullrich for their research, which led to the development of the breast cancer drug Herceptin.
However, if the jury were to break with its tradition of honouring decades-old research, another woman could be well placed for her role in fighting the Covid-19 pandemic.
- Male domination -
Already honoured by almost all other major medicine prizes, Hungarian-born Katalin Kariko could win for her pioneering research which led directly to the first mRNA vaccines to fight Covid-19, made by Pfizer and Moderna.
"There's not only the direct benefit that it gave us to fight the pandemic, it's also the first in a series of very promising applications using this technology," Nobel watcher Ulrika Bjorksten, the head of Swedish public radio's science service, told AFP.
Kariko could be honoured together with her collaborator Drew Weissman of the United States and Pieter Cullis of Canada.
Last year, the prize went to US researchers David Julius and Ardem Patapoutian for their discoveries on human receptors for temperature and touch.
David Pendlebury, who heads the closely watched Clarivate analytics group which lists dozens of possible winners for the Nobel science prizes, said his money was on King and Slamon this year.
But he also mentioned Hong Kong molecular biologist Yuk Ming Dennis Lo, who pioneered the development of non-invasive prenatal testing.
He also developed a new method of detecting cancer early using just a few drops of blood, dubbed liquid biopsies.
With a simple blood draw "you can determine all kinds of possible problems and diseases", Pendlebury said.
Male researchers based in the United States have overwhelmingly dominated the Nobel science prizes through the years.
The various prize committees have insisted they are trying to recognise women's achievements, but say many of the top discoveries were made decades ago when fewer women were involved in high-level research.
Last year, 12 men and one woman won Nobel Prizes, with all of the science nods going to men.
- Anti-Putin prizes? -
For the Literature Prize on Thursday, literary critics told AFP they thought the Swedish Academy may go for a more mainstream author this year, after selecting lesser-known writers the past two years.
Last year, Tanzanian author Abdulrazak Gurnah won, while US poet Louise Gluck was crowned in 2020.
US novelist Joyce Carol Oates, France's Annie Ernaux and Maryse Conde, Russia's Lyudmila Ulitskaya and Canada's Margaret Atwood have all been cited as potential laureates if the committee has its eyes on a woman.
Online betting sites however have France's Michel Houellebecq as the favourite, ahead of British author Salman Rushdie, who was the victim of an attempted murder attack in August.
But it is the Peace Prize that is expected to hold special significance this year.
After Russian journalist Dmitry Muratov won the prize last year together with his Philippine colleague Maria Ressa in the name of freedom of expression, will the Norwegian Nobel Committee award another anti-Putin prize after Moscow's invasion of Ukraine?
Not since World War II has a conflict raged between two countries so close to Oslo.
The International Criminal Court, tasked with investigating war crimes in Ukraine, and the International Court of Justice -- both based in The Hague -- have been mentioned as possible laureates this year.
So have jailed Russian dissident Alexei Navalny and Belarusian opposition leader Svetlana Tikhanovskaya.
If the committee were to focus on the climate crisis, experts tipped Swedish activist Greta Thunberg, possibly together with British environmentalist David Attenborough or other activists such as Sudan's Nisreen Elsaim and Ghana's Chibeze Ezekiel.
bur-map-aco-phy/po/imm
V.Fontes--PC